Intrathecal baclofen for the management of hereditary spastic paraparesis: a systematic review
{{output}}
This systematic review aims to evaluate the use of intrathecal baclofen (ITB) for hereditary spastic paraparesis (HSP) treatment. An extensive search in two electronical databases was performed. We identified articles published between 1990 and 2022 (PubMed, S... ...
